← FDA Drug Approvals (Drugs@FDA)
SILDENAFIL CITRATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GRANULES · Approved 2023-12-01
Drug application
- FDA Application #
ANDA214556- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- SILDENAFIL CITRATE
- Generic name
- Sildenafil Citrate
- Active ingredients
- SILDENAFIL CITRATE
- Dosage form
- FOR SUSPENSION
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- GRANULES
- First approval
- 2023-12-01
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown